A new AI model, developed by IBM Research and Pfizer, has used short, non-invasive and standardized speech tests to help predict the eventual onset of Alzheimer’s disease within healthy people with an accuracy of 0.7 and an AUC of 0.74 (area under the curve).
In Collaboration with the National Institutes of Health, IBM Research Dives Deep into Biomarkers of Schizophrenia
In collaboration with researchers from Harvard Medical School, Mt. Sinai School of Medicine, Stanford University and the Northern California Institute for Research and Education, IBM Research is undertaking a new research initiative funded by the National Institute of Health.
In a new study, IBM and CHDI researchers studied the relationship between the pace of subtle cognitive decline in patients before full-fledged symptoms and their brain activity, as shown by a functional MRI. The results demonstrate that measuring the potential progression of HD could eventually be done from a single brain scan, acquired in one visit.